Stifel analysts increased their price target on New Fortress Energy shares (NASDAQ:NFE) to $23.00, up from the previous $17.00, while reiterating a Buy rating on the stock. According to InvestingPro ...

CEO Ron Kruszewski and Yahoo Finance Executive Editor Brian Sozzi at the 2025 World Economic Forum in Davos, Switzerland, to talk about the macro issues impacting the investment banking firm, ...

Stifel analysts reiterated their Buy rating on shares of IBM (NYSE:IBM), keeping the price target steady at $246.00. The firm's stance comes with an expectation of seasonal strength in the fourth ...

Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...

Stifel raised the firm’s price target on Old Dominion (ODFL) to $193 from $176 and keeps a Hold rating on the shares. 2024 largely proved to be ...

Stifel raised the firm’s price target on TFI International (TFII) to $147 from $139 and keeps a Hold rating on the shares. 2024 largely proved ...

Down 15-2 just a few minutes into their contest, it would take a monumental effort for the Wheeling Central Maroon Knights to ...

Equities researchers at Stifel Canada lifted their FY2024 earnings per share (EPS) estimates for shares of Kits Eyecare in a research note issued on Monday, January 20th. Stifel Canada analyst M.

On Tuesday, Canoo Inc (GOEV) stock saw a decline, ending the day at $0.37 which represents a decrease of $-0.98 or -72.59% from the prior close of $1.35. The stock opened at $0.39 and touched a low of ...

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...